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Francisella tularensis (Ft) is a category A biothreat agent for which there is no Food 
and Drug Administration-approved vaccine. Ft can survive in a variety of habitats with 
a remarkable ability to adapt to changing environmental conditions. Furthermore, Ft 
expresses distinct sets of antigens (Ags) when inside of macrophages (its in vivo host) as 
compared to those grown in vitro with Mueller Hinton Broth (MHB). However, in contrast to 
MHB-grown Ft, Ft grown in Brain-Heart Infusion (BHI) more closely mimics the antigenic 
profile of macrophage-grown Ft. Thus, we anticipated that when used as a vaccine, BHI-
grown Ft would provide better protection compared to MHB-grown Ft, primarily due to 
its greater antigenic similarity to Ft circulating inside the host (macrophages) during nat-
ural infection. Our investigation, however, revealed that inactivated Ft (iFt) grown in MHB 
(iFt-MHB) exhibited superior protective activity when used as a vaccine, as compared 
to iFt grown in BHI (iFt-BHI). The superior protection afforded by iFt-MHB compared to 
that of iFt-BHI was associated with significantly lower bacterial burden and inflammation 
in the lungs and spleens of vaccinated mice. Moreover, iFt-MHB also induced increased 
levels of Ft-specific IgG. Further evaluation of early immunological cues also revealed 
that iFt-MHB exhibits increased engagement of Ag-presenting cells including increased 
iFt binding to dendritic cells, increased expression of costimulatory markers, and 
increased secretion of pro-inflammatory cytokines. Importantly, these studies directly 
demonstrate that Ft growth conditions strongly impact Ft vaccine efficacy and that the 
growth medium used to produce whole cell vaccines to Ft must be a key consideration 
in the development of a tularemia vaccine.
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inTrODUcTiOn
Whole cell-based vaccines are preferred in the absence of well-defined protective immunogens. In 
addition, whole cell-based vaccines provide a broad range of potential protective antigens (Ags) 
and immune stimulatory molecules, which can include proteins, polysaccharides, and pathogen-
associated molecular pattern molecules (PAMPs). In the absence of an identified protective Ag, 
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directing the immune response toward an array of Ags that the 
host is likely to encounter during a natural infection maximizes 
the potential for a protective immune response to be generated 
upon vaccination. In this regard, the composition of the anti-
genic repertoire expressed by the constituent whole cell vaccine 
becomes very important, while PAMPs can provide molecular 
components required for the activation of Ag-presenting cells 
(APCs). Furthermore, activation of APCs is a key requirement for 
the generation of an optimal adaptive immune response against 
cognate Ags contained within such vaccines.
Importantly, the in vitro culture medium utilized to generate 
whole cell-based vaccines can significantly impact the expression 
of antigenic determinants and PAMPs on the infectious agent. 
Several microbes have been shown to differentially express 
Ags depending on the growth medium utilized, including 
Escherichia coli, Salmonella enterica (1), Listeria monocytogenes 
(2), Helicobacter pylori (3), and Mycobacterium bovis (BCG) 
(4, 5). Direct evidence supporting an impact of growth medium 
on the efficacy of whole cell-based vaccines comes from a study 
involving BCG where its differential cultivation in Sauton versus 
Middlebrook medium significantly altered its protective efficacy 
(6). However, the mechanism responsible for this apparent differ-
ence has not been well established.
In regard to Francisella tularensis (Ft), it has been found that 
its antigenic repertoire can change depending on the growth 
medium employed for in vitro cultivation. Specifically, we previ-
ously demonstrated that the protein profile expressed by Brain-
Heart Infusion (BHI)-grown Ft closely resembles that of in vivo 
circulating Ft, while Ft grown in Mueller Hinton Broth (MHB) 
exhibits a distinct protein profile (7, 8). Interestingly, other inves-
tigations have revealed that BHI- and MHB-grown Ft also differ 
in their ability to interact with complement and antibodies (9). 
In addition, BHI-grown Ft exhibits a diminished ability to elicit 
pro-inflammatory cytokines by various APCs compared with 
inactivated Ft (iFt)-MHB (10, 11). These features of BHI- versus 
MHB-grown Ft provide unique and necessary tools to investigate 
the dichotomy between the antigenic repertoire versus APC-
activating components of whole cell-based Ft vaccines.
In this study, we examined the differences in protective efficacy 
of iFt vaccine prepared by growth in MHB or BHI and further 
evaluated if the difference in protective efficacy observed reflects 
changes in not only the immune response but also APC function. 
While we initially hypothesized that BHI-grown iFt, which more 
closely mimics the antigenic repertoire of in vivo macrophage-
grown Ft, would provide the superior vaccine immunogen, we 
found that iFt-MHB generates superior protection compared to 
iFt-BHI. Other indicators of protection, such as bacterial burden, 
tissue damage, and production of pro-inflammatory cytokines, 
also correlated with the improved protective efficacy of iFt-MHB 
versus iFt-BHI. Furthermore, we found that iFt-MHB exhibited 
significantly higher binding to APCs, higher induction of den-
dritic cell (DC) maturation, and increased Ag presentation to 
Ft-specific T cells. Overall, this investigation suggests that APC 
activation components are important for protective efficacy of 
inactivated whole cell-based vaccines. Moreover, growth condi-
tions employed to prepare these vaccines can significantly influ-
ence their immunological and protective efficacy.
MaTerials anD MeThODs
Mice
Six- to 8-week-old male and female C57Bl/6 mice were obtained 
from Taconic laboratories (Hudson, NY, USA). Mice were 
housed in the animal resource facility at Albany Medical Center. 
Food and water were provided ad libitum during the entirety of 
experiments. Animal studies were reviewed and approved by 
Institutional Animal Care and Use Committee of Albany Medical 
Center according to NIH guidelines.
Preparation of iFt
Francisella tularensis LVS was grown in MHB (Becton, Dickinson, 
Franklin Lakes, NJ, USA) or BHI (Becton, Dickinson) medium at 
37°C to a density of ~0.5–1 × 109 colony-forming units (CFU)/
ml. To inactivate Ft LVS, 1 × 1010 CFU/ml of live bacteria were 
incubated in 1  ml of sterile phosphate-buffered saline (PBS) 
(Sigma-Aldrich, St. Louis, MO, USA) containing 2% paraformal-
dehyde (Sigma-Aldrich) for 2 h at room temperature with gentle 
shaking. Subsequently, fixed bacteria (iFt) were washed with 
sterile PBS three times. Inactivation was verified by culturing a 
100 µl of sample (1 × 109 iFt organisms) on chocolate agar plates 
(Becton, Dickinson) for 7 days. Protein contents were quantified 
using a bicinchoninic acid assay (Sigma-Aldrich) as described 
(12). The iFt preparations were resuspended in PBS and stored in 
1 ml aliquots at −20°C until use. Ft LVS for challenge was grown 
similarly and stored in liquid nitrogen until use.
immunization and challenge
Groups of six to eight mice with equal numbers of males and 
females were immunized on day 0 and 21 via the intranasal (i.n.) 
route. Each mouse was anesthetized by intraperitoneal injection 
of 20% ketamine plus 5% xylazine and subsequently administered 
20 µl of PBS (vehicle), iFt-MHB, or iFt-BHI at a concentration of 
37.5 ng, 75 ng, 150 ng, or 300 ng/20 μl. Immunized mice were then 
challenged on day 35 i.n. with 2× LD50 of Ft in 40 µl of PBS (single 
nostril) and subsequently monitored for survival for 21 days.
Quantification of Bacterial Burden
Following immunization and challenge, mice were euthanized 
at various time intervals, and lung and spleen were collected 
aseptically in PBS-containing protease inhibitor mixture (Roche 
Diagnostics, Indianapolis, IN, USA) and subjected to mechanical 
homogenization using Mini Bead Beater-8 (BioSpec Products, 
Bartlesville, OK, USA) using 1-mm zirconia/silica beads. Tissue 
homogenates were then diluted 10-fold in sterile saline, and 10 µl 
of each dilution was spotted onto chocolate agar plates in dupli-
cate and incubated at 37°C for 48 to 72 h. The number of colonies 
on the plates were counted and expressed as CFU per milliliter for 
the respective tissue. Tissue homogenates were then centrifuged 
at 14,000 g for 20 min, and the clarified homogenates were stored 
at −20°C for subsequent cytokine analysis.
lactate Dehydrogenase (lDh) assay
Serum LDH levels were quantified following the manufacturer’s 
instructions (Sigma-Aldrich). Briefly, mice were immunized and 
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challenged as described for quantification of bacterial burden. Sera 
were collected on days 1, 3, 5, and 7 postinfection. Prechallenge 
sera were collected 11 days after booster immunization. Serum 
samples were diluted 1:100 with LDH assay buffer. Fifty microlit-
ers of diluted serum samples, standard, and blanks was added 
to separate wells in a 96-well microtiter plate. Fifty microliters 
of LDH substrate was subsequently added to each well. LDH 
converts NAD to NADH, which can be read calorimetrically at 
450 nm. The amount of NADH generated between Tinitial (absorb-
ance at 450 nm immediately after the LDH substrate) and Tfinal 
(absorbance at 450 nm immediately after the LDH substrate) by 
the LDH activity is first calculated (B). The LDH activity of the 
sample is determined by the formula LDH activity = (B × sample 
dilution factor)/(reaction time × V), where V is the sample volume 
added to well. LDH activity is reported as milliunit per milliliter.
antibody (ab) Titer Determination
Anti-Ft-Ab production in response to immunization with iFt-
MHB versus iFt- BHI was measured by ELISA. Briefly, ELISA 
plates (Corning, Corning, NY, USA) were coated with 50 µl of 
Ft LVS (5 ×  107  CFU/ml) in carbonate buffer [4.3  g/l sodium 
bicarbonate (Sigma-Aldrich) and 5.3  g/l sodium carbonate 
(Sigma-Aldrich) at pH 9.4] for 16 h at 4°C. The plates were then 
washed with washing buffer [PBS (Sigma-Aldrich) containing 
0.5% bovine serum albumin (BSA) (Sigma-Aldrich)] and blocked 
for 2 h with 200 µl of PBS containing 5% BSA. Serial threefold 
dilutions of sera (starting with 1/10) were added to the plates 
(100 µl/well) and incubated for 2 h at 4°C. After three washes with 
washing buffer, alkaline phosphatase-conjugated anti-mouse Ab 
specific for IgG (Sigma-Aldrich) was added and incubated for 1 h 
at 4°C. Plates were then washed three times with washing buffer, 
and then 100  µl of BCIP/NBT alkaline phosphatase substrate 
(Sigma-Aldrich) was added. Plates were subsequently incubated 
for 2 h, and absorbance at 405 nm was measured using a micro-
plate reader (Molecular Devices, Sunnyvale, CA, USA).
sodium Dodecyl sulfate Polyacrylamide 
gel electrophoresis (sDs-Page) and 
Western Blot analysis
Samples derived from 10  µg (~1 ×  108 cells) of Ft were mixed 
with Laemmli sample buffer (BioRad, Hercules, CA, USA) and 
boiled for 10  min prior to resolution through 4–12% gradient 
SDS-PAGE precast gels (Invitrogen, Carlsbad, CA, USA). The 
running buffer was NuPAGE MES SDS buffer (Invitrogen). 
Gels were run at 90–160  V. Resolved gels were stained with 
either Coomassie blue (Bio-Rad) or transferred to nitrocel-
lulose membranes. Coomassie-stained gels were scanned into 
Adobe Photoshop. Membranes were then blocked for 30  min 
with PBS, 0.05% Tween 20, 5% non-fat dry milk. Primary Abs 
were applied for overnight incubation at dilutions ranging from 
1:500 to 1:60,000 in PBS-Tween. Following five washes with PBS-
Tween, the membranes were incubated for 1  h with agitation 
with biotinylated goat anti-mouse IgG (H + L, Southern Biotech, 
Birmingham, AL, USA). Following an additional five washes 
with PBS-Tween, the membranes were incubated for 1  h with 
agitation with streptavidin-conjugated horseradish peroxidase 
(Southern Biotech). Development of the chemiluminescent 
substrate (SuperSignal West Pico, Pierce, Rockford, IL, USA) 
was visualized using an Alpha Innotech imaging system in movie 
mode. Densitometric analysis of developed blots was performed 
as previously described (7, 9).
ag-Presenting cells
Dendritic cells were generated from bone marrow cells using 
mouse recombinant FLT-3 (rFLT-3) (R& D systems, Minneapolis, 
MN, USA) following a previously described method (13). 
Briefly, bone marrow cells were obtained from 6- to 8-week-old 
female C57Bl/6 mice and were incubated for 6  days in bone 
marrow-derived DC (BMDC) generation medium [Roswell Park 
Memorial Institute (RPMI) 1640 medium] supplemented with 
10% fetal bovine serum (FBS), 50 ng/ml rFLT-3, 1 mM sodium 
pyruvate (Cellgro, Tewksbury, MA, USA), 2  mM l-glutamine 
(Cellgro), 1× non-essential amino acids (Cellgro), 0.05  mM 
2-Mercaptoethanol (Bio-Rad), and 1× penicillin streptomycin 
(Cellgro). Fifty percent of the medium was replaced with fresh 
BMDC generation medium on day 3 during 6 days of incuba-
tion. Peritoneal exudate cells (PECs) were isolated from naïve 
mice. PECs were cultured with RPMI 1640 supplemented with 
10% FBS, and non-adherent cells were removed by aspiration 
of medium after 24  h. Adherent cells, which comprise >90% 
macrophages, were used as APCs.
iFt Binding assay
Binding of iFt was visualized by flow cytometry using GFP-
expressing iFt, as previously described (13). GFP-expressing Ft 
LVS organisms were provided by Dr. Mats Forsman (Swedish 
Defense Research Agency, Stockholm) (14). Briefly, 1  ×  106 
BMDCs were incubated with 5, 10, 15, or 20 µg of GFP-expressing 
iFt-BHI or iFt-MHB in PBS. After 2 h incubation at 4°C, BMDCs 
were washed twice with PBS and stained with rat anti-mouse 
CD11c-Alexa 700 Ab and subsequently analyzed by flow 
cytometry (LSRII, BD, Franklin Lakes, NJ, USA). The percent of 
GFP-positive CD11c DCs (indicative of iFt bound to DCs) were 
analyzed in respective samples.
In Vitro analysis of costimulatory 
Molecule expression and cytokine 
secretion
Expression of costimulatory molecules on BMDCs was analyzed 
by flow cytometry as previously described (13). Briefly, 2 × 105 
BMDCs were incubated for 24 h with PBS or 10 µg of iFt- MHB 
or iFt- BHI in an equivalent volume of PBS. Cells were then 
harvested and stained with Abs to the following surface markers: 
rat anti-mouse CD40-PE, rat anti-mouse CD80-APC, and rat 
anti-mouse CD86-Alexa 700. Cells were subsequently analyzed 
via flow cytometry.
Cytokine secretion by BMDCs was assayed following previ-
ously described methods (13). Briefly, 2  ×  105 BMDCs were 
incubated with PBS or with 10 µg iFt- MHB or iFt-BHI for 24 h 
at 37°C. Culture supernatants were then collected and analyzed 
for cytokines using the Bio-Plex assay system as described below.
FigUre 1 | Fixed Francisella tularensis (Ft) lVs used herein for 
immunization studies retain the protein composition of their unfixed 
counter parts. Ten micrograms of live and fixed Ft LVS previously grown in 
Mueller Hinton Broth and Brain-Heart Infusion (BHI) were resolved by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis and stained with 
Coomassie blue (a) or transferred for western blot analysis (B). Asterisks in A 
mark bands, which are visibly more abundant in the western blot of 
BHI-grown Ft (B). The membrane was probed with a cocktail of monoclonal 
antibodies specific for IglB, IglC, and a FopA-specific polyclonal mouse 
serum. IglB and IglC have previously been shown to be more abundant in 
BHI-grown Ft (7, 9). FopA is used here as a loading control. The ~18-kDa 
band visible under IglC is an unidentified, endogenously biotinylated Ft 
protein (likely AccB) detected by the streptavidin–horseradish peroxidase 
conjugate used during development of the western blots.
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cytokine analysis
Cytokines were measured using Bio-Plex assay kits (Bio-Rad) 
following the manufacturer’s instructions. Briefly, 50 µl of a 1× 
mixture of magnetic beads coupled with capture Abs for captur-
ing desired cytokines were added to separate wells of flat bottom 
96-well microtiter plate. Beads were washed (2×) with Bio-Plex 
wash buffer. Unless stated otherwise, all incubations were done 
at room temperature with plates sealed with a plastic sealer and 
covered with aluminum foil with gentle shaking. All washing was 
done with Bio-Plex washing buffer. Fifty microliters of diluted 
standards, blank, or samples was added to individual wells. Plates 
were incubated for 30 min and washed 3× with Bio-Plex washing 
buffer. Then 25  µl of 1× mixture of biotinylated detection Abs 
were added to each well and incubated for 30 min. Plates were 
washed again, and 50  µl of phycoerythrin-coated streptavidin 
was added to each well and incubated for 10  min. Plates were 
then rewashed, and 125 µl of assay buffer was added to each well. 
Plates were read via Luminex reader (Bio-Rad), and the quantity 
of each cytokine was deduced using a standard curve included 
in the assay.
ag Presentation assays
Antigen presentation assays were done as previously described 
(13). Briefly, 2 × 105 BMDCs or PECs were incubated overnight 
at 37°C with PBS or 5  µg of iFt-MHB or iFt-BHI. A total of 
1 ×  105 Ft-specific T cells (FT25 6D10 hybridoma cells) (13) 
in 100  µl medium (RPMI 1640 supplemented with 10% FBS) 
were then added to each well. The plate was then incubated at 
37°C for 24 h in CO2 incubator, and supernatants were collected. 
Supernatants were then assayed for interleukin (IL)-5 (secreted 
by these cells in response to Ag) using the Bio-Plex assay as 
described earlier.
statistics
The log-rank (Mantel-Cox) test was used for survival curves. 
One-way analysis of variance or the unpaired Student’s t-test 
was used for the remaining figures. Data analysis was per-
formed using Graph-Pad Prizm 5 (Graph-Pad Software, San 
Diego, CA, USA).
resUlTs
iFt exhibits Protein Profiles similar to its 
live counterpart
Before using iFt as immunogen, we first used SDS-PAGE and 
western blot analysis to examine the impact of our fixation pro-
cedure on the protein composition of Ft LVS. The overall protein 
profile of live and fixed Ft LVS was largely unchanged, although 
the fixed samples did show some expected evidence of cross-
linked Ags (Figure 1A). Consistent with previous reports (7, 9), 
the BHI-derived samples contained elevated levels of ~23 and 
~55 kDa proteins [Figure 1A (asterisks)], which were apparent 
in both the live and fixed bacteria. Western blot analysis indicated 
that the live and fixed BHI-derived samples contained levels of 
IglB and IglC that were elevated relative to their MHB-grown 
counterparts (Figure 1B). Densitometric analysis revealed that 
these increases were on the order of threefold to fivefold (Table 
S1 in Supplementary Material), as reported previously (7, 9). As 
our fixed iFt preparations appeared to be faithful representations 
of their live counterparts, we next examined the vaccine efficacy 
of these immunogens.
iFt-MhB generates superior Protection 
against Ft lVs-induced Mortality versus 
iFt-Bhi
First, we evaluated whether the differential expression of anti-
genic repertoire and PAMPs affected by cultivation in MHB 
versus BHI has any impact on the protective efficacy of iFt. We 
used iFt generated in MHB or BHI to immunize mice. Following 
a lethal challenge with Ft LVS, we observed that iFt- MHB-
immunized mice were better protected than iFt-BHI-immunized 
mice (Figure  2). Of the four doses used, the 150- and 300-ng 
doses exhibited statistically significant differences in the pro-
tection afforded by iFt-MHB versus iFt-BHI (Figures  2C,D). 
Importantly, in Figures 2A–D mice were challenged with MHB 
grown Ft LVS. Thus, to evaluate any potential bias of growth 
medium used to culture the challenge organism (Ft LVS) on the 
outcome of survival, we similarly immunized mice with PBS or 
150 ng of iFt-MHB or iFt-BHI, but challenged with BHI-grown 
Ft LVS Once again, we observed that iFt-MHB provided better 
protection compared to iFt-BHI (Figure 2E).
FigUre 4 | inactivated Francisella tularensis (iFt)-Mueller hinton 
Broth (MhB) induces superior resistance to Ft lVs-induced systemic 
tissue damage compared to that of iFt-Brain-heart infusion (Bhi): 
mice were immunized on days 0 and 21 with phosphate-buffered 
saline (white bars), iFt-MhB (gray bars), or iFt-Bhi (black bars) and 
challenged with Ft lVs grown in MhB. Lactate dehydrogenase activity 
was quantified in serum drawn on indicated days postchallenge. 
Prechallenge sera were drawn 11 days after boost. Each bar represents 
mean ± SE (error bar) of two independent experiments with a total of eight 
mice per group. *p < 0.05.
FigUre 3 | inactivated Francisella tularensis (iFt)-Mueller hinton 
Broth (MhB) better reduces bacterial burden following Ft lVs 
infection as compared to that of iFt-Bhi: mice were immunized as in 
Figure 2 with phosphate-buffered saline (white bars), iFt-MhB  
(gray bars), or iFt-Bhi (black bars) and challenged with Ft lVs grown 
in MhB. Subsequently, Ft LVS colony-forming units were enumerated in the 
lung (a) and spleen (B) homogenates at indicated days postinfection. Each 
bar represents the mean ± SE (error bar) of two independent experiments 
with a total of eight mice per group. ***p < 0.001.
FigUre 2 | inactivated Francisella tularensis (iFt)-Mueller hinton 
Broth (MhB) provides superior protection compared to  
iFt-Brain-heart infusion (Bhi) against lethal Ft lVs challenge. Mice 
were immunized twice on days 0 and 21 with phosphate-buffered saline or 
iFt-MHB or iFt-BHI at a dose of 37.5 ng (a), 75 ng (B), 150 ng (c,e), or 
300 ng (D). (a–D) Mice were infected 2 weeks after booster immunization 
with 2× LD50 of Ft LVS grown in MHB. (e) Mice were infected with 2× LD50 of 
Ft LVS grown in BHI. This figure represents Kaplan–Meier survival curves of 
three independent experiments with a total of 20 mice per group (a–D) or 1 
experiment with 12 mice per group (e). *p < 0.05.
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iFt-MhB-immunized Mice are Better 
Protected against Bacterial replication 
and Tissue Damage following Ft lVs 
infection, as compared to That of iFt-Bhi
Following the above observation of differential protection 
afforded by iFt-MHB versus iFt-BHI, we investigated the ability 
of the two iFt immunogens to protect against bacterial replica-
tion and tissue damage exerted by Ft LVS infection. Following 
immunization and Ft LVS challenge, we found significantly lower 
bacterial burdens in the lungs (Days 5 and 7) (Figure 3A) and 
spleen (Day 7) (Figure 3B) of mice immunized with iFt-MHB as 
compared to that of iFt-BHI.
Francisella tularensis LVS infection inflicts systemic tissue 
damage in infected mice, and serum LDH levels are commonly 
used as a biomarker of tissue damage (15). Thus, we evaluated 
serum LDH levels at early and late stages of Ft LVS infection in 
mice immunized with iFt-MHB versus iFt-BHI. At days 5 and 7 
after Ft LVS infection, significantly lower levels of LDH activity 
were found in iFt-MHB-immunized mice versus that of iFt-BHI-
immunized mice (Figure 4).
Differential Protection against Ft  
lVs-induced inflammation by iFt-MhB 
versus iFt-Bhi
Systemic inflammation and/or sepsis are hallmarks of the 
tularemia in advanced stages of infection. We previously observed 
FigUre 5 | inactivated Francisella tularensis (iFt)-Mueller hinton Broth (MhB) is superior to iFt-Brain-heart infusion (Bhi) in controlling Ft-induced 
inflammation in the lung. Mice were immunized with phosphate-buffered saline (white bars) or 150 ng of iFt-MHB (gary bars) or iFt-BHI (black bars) and 
challenged with Ft LVS Indicated cytokines were quantified in homogenates of lung (a–D) and spleen (e–h) at the indicated days postinfection. Values represent 
mean ± SE (error bar) of two independent experiments with a total of eight mice per group. *p < 0.05.
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that mice protected by immunization exhibit lower levels of pro-
inflammatory cytokines in the lungs and spleens following Ft 
infection, compared to those of unprotected mice (16, 17). In 
this case, analogous to our previous studies, we observed that 
mice immunized with iFt-MHB, which are better protected, also 
exhibited lower levels of IL-6 (Figure 5A), interferon (IFN)-γ 
(Figure 5C), and monocyte chemoattractant protein (MCP)-1 
(Figure  5D) in the lungs in the latter stage of disease (day 7 
postinfection). MCP-1 levels were also lower at day 3 postinfec-
tion in the lungs of iFt-MHB immunized mice compared to that 
FigUre 6 | increased Francisella tularensis (Ft)-specific antibody 
production is induced by inactivated Ft (iFt)-Mueller hinton Broth 
(MhB) versus iFt-Brain-heart infusion (Bhi). Mice were immunized twice 
at a 3-week interval with 20 µl phosphate-buffered saline (PBS) or 150 ng of 
iFt-BHI or iFt-MHB via the intranasal route in 20 µl PBS. Sera obtained 
2 weeks postboost were analyzed for Ft-MHB-specific (a) and  
Ft-BHI-specific (B) IgG. Values represent mean ± SE of two independent 
experiments (n = 16 mice per group). *p < 0.05.
FigUre 7 | inactivated Francisella tularensis (iFt)-Mueller hinton 
Broth (MhB) elicits antibody (ab) against broader range of antigens 
compared to iFt-Brain-heart infusion (Bhi). Ten micrograms of Ft LVS or 
WbtA LVS grown as indicated (M = MHB, B = BHI) were resolved by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis and transferred to 
nitrocellulose membranes for western blot analysis. Membranes were 
incubated overnight with 1:500 dilutions of the indicated sera. Bound Abs 
were detected through sequential incubations with biotinylated goat 
anti-mouse and streptavidin-conjugated horseradish peroxidase (HRP). The 
prominent ~18 kDa band visible in all three blots is an unidentified, 
endogenously biotinylated Ft protein detected by the SA-HRP conjugate.
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of iFt-BHI immunized mice. MCP-1 is a chemoattractant for 
inflammatory monocytes, which can induce to tissue damage. 
Therefore, regulation of MCP-1 levels is important for protec-
tion against systemic tissue damage and subsequent mortality 
inflicted by Ft LVS infection. Interestingly, higher levels of IL-17 
were also found at day 3 postinfection in iFt-MHB immunized 
mice compared to that of iFt-BHI immunized (Figure 5B). IL-17 
has been found to be protective against mucosal infections with 
bacteria including Ft (18, 19). Thus, higher IL-17 levels at early 
stages of infection correlate with superior protection afforded 
by iFt-MHB compared to iFt-BHI. Similarly, in the spleens, 
significantly lower levels of tumor necrosis factor (TNF)-α (at 
day 7 postinfection) (Figure  5F), IFN-γ (day 5 postinfection) 
(Figure  5G), and MCP-1 (day 7 postinfection) (Figure  5H) 
were observed in mice immunized with iFt-MHB compared to 
that of iFt-BHI. However, level of IL6 (Figure 5E) in the spleens 
were comparable among mice immunized with iFt-MHB and 
iFt-BHI.
increased ab responses are induced  
by iFt-MhB versus iFt-Bhi
Next we investigated whether iFt generated in MHB versus BHI 
medium also has a differential impact on the humoral immune 
response against Ft. We quantified Ft-specific serum-IgG by 
ELISA as a measure of humoral immune response to Ft. Live 
Ft LVS grown in BHI and MHB medium were coated onto 
ELISA plates and reacted with sera obtained from iFt-MHB 
versus iFt-BHI-immunized mice. IgG induced by iFt-MHB 
compared to iFt-BHI reacted more strongly to Ft surface Ags 
expressed on both MHB- or BHI-grown Ft LVS, as evidenced 
by their relative titers (Figures 6A,B). This is consistent with 
superior protection afforded by iFt-MHB compared to that of 
iFt-BHI. The choice of Ags employed [Ft-MHB (Figure  6A) 
versus Ft-BHI (Figure  6B)] to detect Ab titers did not alter 
the relative pattern of Ab production observed in iFt-MHB or 
iFt-BHI-immunized mice.
To further characterize these Ab responses, we also used 
the above sera to probe by western blot lysates of MHB- and 
BHI-grown Ft LVS along with a BHI-grown mutant Ft (WbtA), 
which is deficient for O-Ag. As shown in Figure 7, the anti-iFt-
MHB sera recognized a more diverse array of Ags than did the 
anti-iFt-BHI sera. One of the Ags preferentially recognized by 
the anti-iFt-MHB sera appeared to have a ladder pattern typical 
of LPS, and consistent with this, this ladder pattern was mark-
edly reduced/absent in the WbtA mutant Ft. In addition, the Ag 
specificity of the anti-iF-BHI sera appeared to be more focused 
on a ~43  kDa protein with reduced O-Ag-dependent reactiv-
ity. Collectively, the data in Figures 6 and 7, as well as in data 
not shown, indicate that immunization with iFt-MHB induces 
higher titers of anti-Ft Ab and that a larger proportion of this Ab 
is dependent on O-Ag for binding.
iFt-MhB and iFt-Bhi Differentially Bind to 
BMDcs and Differentially induce 
expression of costimulatory Molecules
Having observed differential protective efficacy between iFt 
generated in MHB versus BHI, we sought to further identify the 
immune mechanisms underlying the differences in protective 
efficacy of iFt-MHB versus iFt-BHI. In our previous studies 
(7, 9) and Figure 1, we demonstrated that iFt-BHI exhibits an 
antigenic profile more similar to that of in vivo circulating Ft, as 
apposed to that of Ft-MHB. This is in contrast to our expectation 
that by virtue of exposing the host to iFt-BHI, which is more 
similar antigenically to in vivo replicating Ft, a better protective 
immune response would be achieved. This led us to further 
investigate the immune mechanisms responsible for this unex-
pected observation.
FigUre 8 | enhanced binding of inactivated Francisella tularensis (iFt)-Mueller hinton Broth (MhB) to antigen-presenting cells (aPcs) as compared 
to iFt-Brain-heart infusion (Bhi). Bone marrow-derived dendritic cells (BMDCs) were incubated with GFP-expressing iFt-BHI or iFt-MHB. Cells were washed and 
stained with CD11c antibody before analyzing with flow cytometry for GFP signal associated with BMDCs (a). (B) Percentage of GFP-positive (+) BMDCs as 
evaluated by flow cytometry. Values represent mean ± SE of two independent experiments. ***p < 0.001.
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By using a GFP-expressing Ft LVS, we investigated whether 
iFt generated in MHB versus BHI have different abilities to bind 
to and activate APCs. In fact, we observed significantly higher 
binding of iFt-MHB-(GFP) to BMDCs compared to iFt-BHI-
(GFP) (Figure 8). Increasing the concentration of the iFt-MHB-
(GFP) successively increased the number of BMDCs harboring 
iFt-MHB. In contrast, iFt-BHI-(GFP) exhibited relatively poor 
binding to BMDCs at all concentrations used in this assay. 
Furthermore, costimulatory molecules are essential components 
for T cell activation. As demonstrated in Figure  9, iFt-MHB 
induced significantly higher expression of the costimulatory 
molecules CD80 (Figures 9A,B) and CD86 (Figures 9C,D), as 
compared to iFt-BHI, although CD40 (Figures 9E,F) expression 
was stimulated to a similar degree by both immunogens.
iFt-MhB Mediates higher  
Pro-inflammatory cytokine Production 
and increased ag Presentation  
to Ft-specific T cells
In addition to Ag binding and expression of costimulatory 
molecules on APCs, secretion of pro-inflammatory cytokines 
is also critical for DC-mediated orchestration of the adaptive 
immune response. We observed that iFt-MHB induces higher 
levels of the pro-inflammatory cytokines [IL-1β (Figure 10A), 
IL-6 (Figure  10C), and TNF-α (Figure  10D)], as compared 
to iFt-BHI, while both immunogens induced similar levels of 
IL-10. Finally, we investigated the presentation of iFt-MHB 
versus iFt-BHI using an Ft-specific T cell hybridoma (FT25 
6D10), which is specific to an epitope corresponding to Ft 
50 s-ribosomal protein (20) and secretes IL-5 on engagement 
with cognate major histocompatibility complex (MHC)-
peptide complex (13). Co-cultures of FT25 6D10 and APCs 
(PECs or BMDCs) exposed to iFt-MHB exhibited higher levels 
of IL-5 compared to that of iFt-BHI (Figure  11). Together, 
data presented in Figures 8–10 suggest that iFt-MHB harbors 
a superior ability to stimulate APC function as compared to 
iFt-BHI.
DiscUssiOn
In the present investigation, we observed that iFt propagated 
in MHB versus BHI medium exhibits a differential ability to 
stimulate an immune response to and protection against Ft 
challenge. Specifically, iFt-MHB immunogen induced improved 
protection against lethal Ft LVS challenge as compared to iFt-
BHI. Consistent with the superior protective activity of iFt-MHB 
immunogen, bacterial burden and tissue damage were also 
reduced. Furthermore, immunization with iFt-MHB leads to 
reduced inflammation in the lungs and spleens. Importantly, 
it has been demonstrated that mice protected against Ft LVS 
challenge via immunization exhibit lower pro-inflammatory 
cytokines in their lungs and spleen late in infection (16, 17), 
which we also observed in the case of iFt-MHB immunization. 
FigUre 9 | induction of higher expression of costimulatory molecules on antigen-presenting cells by inactivated Francisella tularensis (iFt)-Mueller 
hinton Broth compared to iFt-Brain-heart infusion (Bhi). Bone marrow-derived dendritic cells were incubated with iFt-BHI and iFt-MHB for 24 h. Expression 
of indicated cell surface markers were analyzed via flow cytometry (a,c,e). (B,D,F) The MFI of respective markers. Values represent mean ± SE of two independent 
experiments. *p < 0.001.
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Notably, in contrast to the above, however, we observed elevated 
levels of IL-17 in lungs of mice immunized with iFt-MHB on 
day 3 postinfection with Ft LVS IL-17 has been implicated in 
protection against mucosal infections including Ft LVS (18, 19). 
FigUre 10 | inactivated Francisella tularensis (iFt)-Mueller hinton 
Broth (MhB) elicits greater pro-inflammatory cytokine production 
compared to iFt-Brain-heart infusion (Bhi). Bone marrow-derived 
dendritic cells were incubated with phosphate-buffered saline, iFt-BHI, or 
iFt-MHB for 24 h. Supernatants were analyzed for (a) IL1B, (B) IL10, (c) IL6, 
and (D) TNF-α. Values presented are mean ± SE of two independent 
experiments. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
FigUre 11 | relative presentation of inactivated Francisella tularensis 
(iFt)-Brain-heart infusion (Bhi) and iFt-Mueller hinton Broth (MhB) by 
antigen-presenting cells (aPcs): aPcs [peritoneal exudate cells (a) or 
bone marrow-derived dendritic cells (B)] were exposed to phosphate-
buffered saline or 10 µg of iFt-MhB or iFt-Bhi for 24 h. FT25 6D10 cells 
were then mixed with the APCs and incubated for 24 h. Supernatants were 
then collected analyzed for interleukin-5. Values represent mean ± SE of two 
independent experiments. *p < 0.05, **p < 0.01.
Immunization with iFt-MHB also induced higher levels of Ft-
specific IgG, which have been shown to play a role in protection 
against Ft LVS (21). Apart from quantitative differences in IgG 
titers, Abs produced in response to iFt-MHB and iFt-BHI also 
differed qualitatively. While the dominant reactivity of anti-iFt-
BHI was to a 43  kDa protein, the anti-iFt-MHB response was 
more broadly distributed among a range of Ags including Ft 
LPS (O-Ag). Ft LPS has been found to be an important Ag for 
protection against Ft infection (22). Although, at present, we do 
not know the significance of the differences in the Ab responses 
elicited by iFt-MHB versus iFt-BHI, further studies in this regard 
may reveal their impact on protection.
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In regard to the mechanisms(s) by which iFt-MHB is a 
better immunogen, APCs are the gateway to adaptive immune 
response. APCs present Ags to T cells in association with MHC, 
which provides the primary signal for T cell activation. Other 
signals required for T cell activation include costimulatory 
molecules, e.g., CD80 and CD86 (23–25). T cells that receive 
signals only via TCR by engagement with MHC-peptide com-
plex, without receiving the second signal from costimulatory 
ligands, are destined to undergo anergy (26). Moreover, the 
local cytokine niche determines the type of T cell response gen-
erated. For example, IL-12 and IFN-γ favor a T helper 1 immune 
response, while IL-10 and transforming growth factor-β favor a 
regulatory T cell immune response (27, 28). Furthermore, APCs 
can be activated to express MHC II, costimulatory molecules, 
and pro-inflammatory cytokines by exposing them to various 
pathogen-associated molecular patterns (23). Therefore, it is 
important that APCs are exposed to vaccine Ags in the context 
of appropriate APC activation signals (29). In this investiga-
tion, iFts derived from growth in MHB medium exhibited a 
superior ability to activate APCs versus iFt-BHI. Specifically, 
MHB-derived iFt exhibited an increased ability to induce 
CD80 and CD86 on BMDCs. iFt-MHB also induced higher 
pro-inflammatory cytokine production in BMDCs. Moreover, 
we also observed higher levels of Ag presentation/T cell activa-
tion induced by BMDCs exposed to iFt-MHB versus to iFt-BHI. 
Notably, iFt-MHB also exhibited comparatively greater binding 
to BMDCs than iFt-BHI. The increased binding may explain 
the higher levels of pro-inflammatory cytokine stimulation and 
Ag presentation by iFt-MHB (Figure  7). Observations from 
other investigators are consistent with our observations (10, 11) 
that iFt-MHB can induce higher pro-inflammatory cytokines 
compared to iFt-BHI. Thus, collectively, it is clear that iFt-MHB 
exhibits a superior ability to impact the nature and magnitude 
of adaptive immune response, thereby enhancing its protective 
efficacy. The apparent differences in APC engagement between 
iFt-MHB and iFt-BHI may be a reflection of their structural dif-
ferences. In this regard, we have demonstrated that BHI-grown 
Ft LVS expresses additional layers of capsular polysaccharides, 
which have been implicated in hindering Fts’ ability to bind 
with complement and Abs (9). Capsular polysaccharides have 
also been implicated in masking TLR2 and Tul4 ligands on the 
surface of Ft (9). Furthermore, Singh et  al  demonstrated that 
Ft grown in MHB exhibited increased engagement of cytosolic 
DNA sensors, possibly due to structural defects resulting in an 
increased release of DNA into cytosol after uptake by APCs, 
thereby inducing AIM 2-dependent cytokine production (11). 
The LPS of Ft LVS has a peculiar structure that minimizes its 
interaction with TLR4. Also, recently it has been shown that 
genetic engineering of microbes that express E. coli LPS sig-
nificantly enhances their TLR4 engagement with bone marrow-
derived macrophage (30). Thus, in future, one potential means 
to improve Fts’ ability to engage and activate APCs may be to 
genetically engineer Ft to express modified TLR agonists such 
as E. coli LPS.
It is also important to note that environmental conditions such 
as temperature, metal ions present, pH, and other media ingredi-
ents used for in vitro growth can significantly influence antigenic 
expression by bacterial pathogens (8). Various investigations have 
FigUre 12 | a model comparing observations when utilizing inactivated Francisella tularensis (iFt)-Mueller hinton Broth (MhB) versus  
iFt-Brain-heart infusion (Bhi) as immunogen. iFt-MHB in comparison to iFt-BHI engages and activates antigen (Ag)-presenting cells (APCs) including 
significantly higher binding, expression of costimulatory molecules (CD80 and CD86) and secretion of pro-inflammatory cytokines [interleukin (IL)-1b, IL-6, and TNF]. 
iFt-MHB Ags are also presented to Ft-specific T cells more efficiently compared to iFt-BHI. Collectively, superior activation of APCs by iFt-MHB results in higher IgG 
response and protection against lethal Ft challenge.
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